SINGLE CHAIN MONOCLONAL ANTIBODY FUSION REAGENTS THAT REGULATE TRANSCRIPTION IN VIVO - Patent 1040201

(19)

(11)

EP 1 040 201 A1

(12)

(43)	Date of publication:
	04.10.2000 Bulletin 2000/40

(21)	Application number: 97949553.8

(22)	Date of filing: 28.11.1997

(51)	International Patent Classification (IPC)⁷: C12Q 1/68, C12Q 1/40, C07K 16/00, C12P 21/08, G01N 33/53, A61K 39/395, A61K 39/40, A61K 39/42, G01N 33/573

(86)	International application number:
	PCT/US9721/407

(87)	International publication number:
	WO 9928/502 (10.06.1999 Gazette 1999/23)

(84)	Designated Contracting States:
	DE FR GB NL

(71)	Applicant: INVITROGEN CORPORATION
	Carlsbad, CA 92008 (US)

(72)	Inventors:
	HOEFFLER, James, P. Carlsbad, CA 92009 (US) RUSSELL, Marijane San Diego, CA 92122 (US)

(74)	Representative: HOFFMANN - EITLE
	Patent- und RechtsanwälteArabellastrasse 4 81925 München 81925 München (DE)

(54)	SINGLE CHAIN MONOCLONAL ANTIBODY FUSION REAGENTS THAT REGULATE TRANSCRIPTION IN VIVO